States Times Review scPurportedly to avoid a legal tussle with national broadsheet The Straits Times, the owner of new website Straits Times Review has since last night changed it’s name to States Times Review.

The website and Facebook page handle currently both reflect the name change, although the URL for its Facebook page remains unchanged.

STR’s Facebook page currently has about 8,000 likes.

Singapore Press Holdings (SPH), which owns The Straits Times, has earlier expressed that it is considering legal action against the website for copyright infringement.

Owner of STR Alex Tan, who is known to be a former editor of The real Singapore, has posted on the website’s Facebook page that he has changed the name to “avoid legal confrontations with The Straits Times”.

The post also ended with a quote from the movie, The Dark Knight: “It’s not who you are underneath, it’s what you do that defines you.”

Tan has earlier posted a challenge to SPH, indicating that he has applied for Trademark registration for “Straits Times Review”.

Tan has also claimed that the website has earlier  encountered problems with its server due to high traffic.

Media reports indicated that “SPH informed (Tan) that the company has ‘trademark rights, goodwill and other related legal rights’ in the name ‘The Straits Times’ and that it did not agree the term ‘Straits Times’ was ‘general and open for public naming’.”

SPH also indicated that Malaysia’s New Straits Times had historical links with The Straits Times in the past and “they are using their name by agreement”.

SPH has also insisted that Tan changes the name of the website and Facebook page, including the links, and to refrain from using such trade marks again, or risk trademark infringement.

Subscribe
Notify of
2 Comments
Newest
Oldest Most Voted
Inline Feedbacks
View all comments
You May Also Like

含超标致癌物 卫生科学局回收三含药物

卫生科学局召回三种含有超标致癌物的药物二甲双胍(metformin)。据悉二甲双胍被广泛用于治疗初期二型糖尿病患。 卫生科学局昨日(4日)发文告表示,在测试了46种二甲双胍药物中,发现三种药物含有可能超标致癌物“N-亚硝基二甲胺”(简称NDMA)。 惟,卫生科学局澄清说受影响的药物由于在我国售卖时间不长,因此对病人并不会造成太大的风险。 卫生科学局正与供应商以及国际组织合作核实受影响原因,日后也会提出相关措施应对。 由于停止使用药物会使血糖突然攀升,为避免造成更大的风险,卫生科学局也呼吁民众不要擅自停止使用,可以和主治医师沟通。 此外,卫生科学局也建议医疗人员应尽快安排病患更换药物。 N-亚硝基二甲胺通常出现在加工食品、肉制品与低水平的空气污染中。最近还发现,出现在部分药物中。目前全球已遭会发现含有这些杂质的药物 美国食品和药物管理局(FDA)周三(12月4日)表示,该机构正在对美国市场售卖的抗糖尿病药物二甲双胍进行抽样检查,若有必要就会召回相关药物。 欧洲药品管理局(EMA)则表示,至今尚未发现欧盟市场所售卖的二甲双胍含超标的NDMA。病人应该继续服用医生所开的药物。

MOH looking into actual cause of death of COVID-19 confirmed patient

In a COVID-19 update yesterday (8 April), the Ministry of Health (MOH)…